Changing Trial Endpoints: When Is an Adaptation Defensible?
Assess a proposed trial endpoint change using prespecification, operating characteristics, information access, and applicable amendment procedures.

Topic
Protocol language that makes endpoint intent operational.
Assess a proposed trial endpoint change using prespecification, operating characteristics, information access, and applicable amendment procedures.

How a protocol team can screen core outcome sets in the COMET database, check scope, development and currency, and document the adoption decision.

Define retained safety data, justified CRF reductions, regional exceptions and escalation plans under ICH E19 for qualifying late-stage trials.

How clinical trial teams write executable endpoint definitions in ICH M11 Section 3, integrating SPIRIT-Outcomes elements and aligning Sections 1.3, 7, 8, and 10.

A methodological guide to identifying critical-to-quality endpoint factors under ICH E8(R1) and locking definitions, estimands, and feasibility before protocol freeze.

A clinical trial guide for reconciling protocol and lab-manual identity when offered substitute collection kits, separating transport compliance from endpoint assay comparability.

A structured clinical trial guide for documenting therapy identity, supply responsibility, and actual exposure when routine-care or background regimens encounter insurance coverage delays before biostatisticians classify an intercurrent event.

A practical release framework for endpoint and data management leads: separating eCOA measurement alterations from schedule and configuration changes under 21 CFR 312.30, 21 CFR 56.108, final PFDD Guidance 3, and EMA Annex 2.10.
